Novolin

Who wins, who loses with biogenerics
Marketwatch
Wed, 09/2/09 - 09:43 am
biogenerics
Neupogen
Amgen
Betaseron
Bayer
Humulin
Eli Lilly
Novolin
Novo Nordisk
Pulmozyme
Roche
Intron A
Infergen
Three Rivers Pharmaceuticals